Skip to main content
Journal of Pharmacy & Bioallied Sciences logoLink to Journal of Pharmacy & Bioallied Sciences
. 2026 Jan 12;18(Suppl 1):S257–S259. doi: 10.4103/jpbs.jpbs_1656_25

Assessment of Obstructive Sleep Apnea (OSA) Risk in Western Region of Gujarat – A Cross-Sectional Study

Naresh Parmar 1, Vivek K Sharma 1, Rajesh Kathrotia 1,, Pradip Barde 1, Gaurav Sharma 1, Vinay Chitturi 1, Ayushi Parmar 1
PMCID: PMC12995048  PMID: 41853037

Abstract

Background:

Obstructive sleep apnea (OSA) remains underdiagnosed in India because polysomnography (PSG) is costly and not widely available. The STOP-Bang questionnaire offers a simple and reliable method to screen high-risk individuals in outpatient settings.

Methods:

A cross-sectional study was conducted among 368 adults attending a tertiary-care hospital in western Gujarat. All participants completed the STOP-Bang questionnaire. A score ≥5 was classified as high-risk for OSA. Data were analyzed using SPSS v24.

Results:

Out of 368 participants, 82 (22.8%) were in the high-risk group (STOP-Bang ≥5), while 277 (77.2%) were low-moderate risk. High-risk scores were significantly more common in males, participants aged >50 years, and those with higher body mass index (BMI).

Conclusion:

About one-fourth of adults screened in this OPD cohort were at high risk for OSA. STOP-Bang proved practical, low-cost, and suitable for early triage in regions where access to PSG is limited.

KEYWORDS: Gujarat, obstructive sleep apnea, polysomnography, screening questionnaire, STOP-bang

INTRODUCTION

Obstructive sleep apnea (OSA) is now recognized as a major sleep-related breathing disorder causing repeated upper-airway obstruction with oxygen desaturation and arousals.[1] Recent global data suggest OSA affects nearly one billion adults and still remains widely underdiagnosed in many regions.[2] It is strongly linked with hypertension, cardiovascular disease and metabolic complications that increases long-term morbidity.[1]

Polysomnography (PSG) is the diagnostic gold standard, but it is costly and less accessible in many Indian hospitals.[3] Because of poor availability of PSG validated screening tools are required for early identification of high-risk individuals.[4]

STOP-Bang questionnaire remains one of the most reliable tools due to high sensitivity and ease of administration in outpatient settings.[5] Recent Indian studies also show STOP-Bang performs well even in non-obese patients who may have craniofacial or anatomical risk factors.[6] Community awareness about OSA in India is still low and many high-risk patients present late with complications.[7] Western India continues to have limited sleep-lab facilities, making OPD-level screening essential.[8]

Therefore, this study was done to estimate the proportion of adults at high risk for OSA using STOP-Bang in a tertiary-care population of Western Gujarat and to identify key associated demographic predictors.

MATERIALS AND METHODS

This cross-sectional observational study was conducted among adults attending the outpatient department of a tertiary care hospital in western Gujarat to identify undiagnosed high-risk individuals for OSA using a standardized screening tool. The study followed the principles of the Declaration of Helsinki. Ethical clearance was obtained from the Institutional Ethics Committee before initiation of the study (IEC/02/2023 PROTOCOL ID NF/45 dated March 17, 2023). Participation was voluntary, and written informed consent was taken from all subjects. No invasive procedure was conducted.

A total of 368 adults aged 18 years and above from different districts of western Gujarat were included. Participants were recruited using a convenience sampling method from the outpatient department during the study period. Patients already diagnosed with OSA or on treatment for sleep disorders were excluded.

All participants completed the STOP-Bang questionnaire, which has eight yes/no questions—four symptom-based (snoring, tiredness, observed apnea, hypertension) and four demographic or anthropometric (BMI >35 kg/m2, age >50 years, neck circumference >40 cm, male gender in Table 1).[3] Each “Yes” scored 1 point, giving a total score of 0–8. Risk was classified as low (0–2), intermediate (3–4), and high (5–8). Those scoring ≥5 were considered high risk and advised overnight PSG [Table 2].[3]

Table 1.

Key participant characteristics

Variable Count (n) % (of 368)
Male 161 43.8%
Age >50 years 247 67.1%
BMI >35 kg/m2 2 0.5%
Neck circumference ≥40 cm 2 0.5%
Snoring (Yes) 294 79.9%
Tiredness/daytime sleepiness (Yes) 295 80.2%
Observed apnea (Yes) 15 4.1%
Known hypertension (Yes) 142 38.6%

BMI=Body mass index

Table 2.

STOP-Bang risk classification

STOP-Bang category Count (n) % (of 368)
Low to moderate risk (STOP-Bang score <5) 286 77.7%
High risk (STOP-Bang score ≥5) 82 22.3%
Total 368 100%

Duly filled questionnaires were verified by the investigator and coded before entry in Microsoft Excel. Data were analyzed using IBM SPSS version 24. Descriptive statistics and cross-tabulations were used to assess the relation of demographic variables with OSA risk.

RESULTS

A total of 368 participants were analyzed. Males were 161 (43.8%) and 247 (67.1%) were older than 50 years. Only two participants (0.5%) had BMI >35 kg/m2 and 2 (0.5%) had neck circumference ≥40 cm. Snoring was reported by 294 (79.9%) and daytime tiredness by 295 (80.2%). Observed apnea was uncommon (15, 4.1%) while known hypertension was present in 142 (38.6%).

By STOP-Bang scoring, 286 participants (77.7%) fell into the low-to-moderate risk group (score <5) and 82 (22.3%) were high risk (score ≥5). Overall high-risk burden in this outpatient sample was 22.3%.

DISCUSSION

In this study we found that 22.3% adults in western Gujarat were in high-risk OSA group based on STOP-Bang score ≥5, which is clearly higher than German community data where only 6.7% screened positive.[4] This difference can be because our sample had more older adults, 67.1% above 50 years, and age increases airway collapsibility due to reduced pharyngeal muscle tone and structural narrowing.[1] Male proportion was also high (43.8%) and male upper-airway anatomy with higher soft tissue mass makes them more prone for obstruction during sleep.[9] Snoring and daytime tiredness were reported by almost 80% participants, which itself drives STOP-Bang score upward and may inflate high-risk proportion compared to cohorts with lower symptom burden.[10]

BMI >35 kg/m2 and neck circumference ≥40 cm was rare in our population, yet risk remained high. This supports evidence that STOP-Bang retains performance even in lower BMI Asian phenotypes where craniofacial narrowing plays a greater role than obesity.[11] Indian studies also show higher OSA risk despite modest BMI because of retrognathia and smaller airway size.[12] Our results align with this pattern as age and male gender became key drivers rather than obesity.

ESS alone has limited value in such settings because many Indians under-report sleepiness, considering fatigue as routine lifestyle burden.[13] Hence STOP-Bang is more sensitive due to both symptoms and objective demographic factors, making it a better triage tool for primary-care screening.[14,15] Global reviews also confirm STOP-Bang as practical, fast, and adaptable across clinical and community settings.[7]

The finding of 22.3% high-risk individuals also reflects hospital-based sampling. Such settings tend to include patients with hypertension or metabolic issues who already have higher underlying OSA risk.[14] Hypertension in our cohort was 38.6%, and OSA contributes to sympathetic activation and BP rise, making the association clinically important.[1]

OSA has strong downstream cardiovascular impact including HF, AF, and stroke, hence missed diagnosis increases later disease burden.[15] Western Gujarat still has limited access to overnight PSG, so validated screening questionnaires are needed to detect risk early and prioritize PSG for those with highest score.[10]

Overall, our findings show that STOP-Bang is useful for early risk stratification even in populations with low obesity levels. Male sex, older age, and heavy snoring pattern mainly pushed risk up in our sample. High-risk individuals should be referred for confirmatory PSG, lifestyle counselling, and early cardiovascular assessment, especially in low-resource regions where diagnostic facilities are few.[10]

CONCLUSION

Our study highlights the rising risk of OSA among the population in Gujarat and reinforces the utility of validated screening tools like STOP-Bang and ESS, especially in low-resource settings

Conflicts of interest

There are no conflicts of interest.

Funding Statement

Nil.

REFERENCES

  • 1.Veugen CCAFM, Teunissen EM, den Otter LAS, Kos MP, Stokroos RJ, Copper MP. Prediction of obstructive sleep apnea: Comparative performance of three screening instruments on the apnea-hypopnea index and the oxygen desaturation index. Sleep Breath. 2021;25:1267–75. doi: 10.1007/s11325-020-02219-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Scharf MT. Reliability and efficacy of the Epworth sleepiness scale: Is there still a place for it? Nat Sci Sleep. 2022;14:2151–6. doi: 10.2147/NSS.S340950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chung F, Abdullah HR, Liao P. STOP-Bang questionnaire. Chest. 2015;149:631–8. doi: 10.1378/chest.15-0903. [DOI] [PubMed] [Google Scholar]
  • 4.Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284:3015–21. doi: 10.1001/jama.284.23.3015. [DOI] [PubMed] [Google Scholar]
  • 5.Farney RJ, Walker BS, Farney RM, Snow GL, Walker JM. The STOP-Bang equivalent model and prediction of severity of obstructive sleep apnea: Relation to polysomnographic measurements of the apnea/hypopnea index. J Clin Sleep Med. 2011;7:459–65B. doi: 10.5664/JCSM.1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–5. doi: 10.1056/NEJM199304293281704. [DOI] [PubMed] [Google Scholar]
  • 7.Cho T, Yan E, Chung F. The STOP-Bang questionnaire: A narrative review on its utilization in different populations and settings. Sleep Med Rev. 2024;78:102007. doi: 10.1016/j.smrv.2024.102007. [DOI] [PubMed] [Google Scholar]
  • 8.Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: An American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2017;13:479–504. doi: 10.5664/jcsm.6506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Franklin KA, Lindberg E. Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis. 2015;7:1311–22. doi: 10.3978/j.issn.2072-1439.2015.06.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Veasey SC, Rosen IM. Obstructive sleep apnea in adults. N Engl J Med. 2019;380:1442–9. doi: 10.1056/NEJMcp1816152. [DOI] [PubMed] [Google Scholar]
  • 11.Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:136–43. doi: 10.1513/pats.200709-155MG. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 1991;14:540–5. doi: 10.1093/sleep/14.6.540. [DOI] [PubMed] [Google Scholar]
  • 13.Harris D, Sokolow B, Sundar K, Ludwig K. Comparative study of the STOP-BANG questionnaire, ApneaLinkTM, and polysomnography for obstructive sleep apnea. Chest. 2011;140:944A. [Google Scholar]
  • 14.Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. Circulation. 2008;118:1497–518. [PubMed] [Google Scholar]
  • 15.Wang Y, Fietze I, Salanitro M, Penzel T. Comparison of the value of the STOP-BANG questionnaire with oxygen desaturation index in screening obstructive sleep apnea in Germany. Sleep Breath. 2023;27:1315–23. doi: 10.1007/s11325-022-02727-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Pharmacy & Bioallied Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES